Gts Securities LLC Novo Nordisk A S Call Options Transaction History

Gts Securities LLC

  • $46.5 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$122.71 - $146.91 $834,428 - $998,988
6,800 Added 8.37%
88,000 $12.6 Million
Q1 2024

May 15, 2024
SELL
$102.11 - $135.92 $3.71 Million - $4.93 Million
-36,300 Reduced 30.89%
81,200 $10.4 Million
Q4 2023

Feb 14, 2024
SELL
$87.78 - $105.45 $3.84 Million - $4.61 Million
-43,700 Reduced 27.11%
117,500 $12.2 Million
Q3 2023

Nov 15, 2023
BUY
$90.94 - $199.54 $14.7 Million - $32.2 Million
161,200 New
161,200 $14.7 Million

Others Institutions Holding NVO

# of Institutions
1,971
Shares Held
320M
Call Options Held
5.16M
Put Options Held
4.96M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email